Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v2-FR
Language English French
Date Updated 2019-10-26 2019-09-05
Drug Identification Number 02327562 02327562
Brand name ACT OLANZAPINE ODT ACT OLANZAPINE ODT
Common or Proper name OLANZAPINE ODT OLANZAPINE ODT
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients OLANZAPINE OLANZAPINE
Strength(s) 5MG 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 30 30
ATC code N05AH N05AH
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-09-05 2019-09-05
Estimated end date Unknown Unknown
Actual end date 2019-10-25
Shortage status Resolved Anticipated shortage
Company comments Item is discontinued
Health Canada comments